Key facts
- Notable investors include Health Incubator Helsinki.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Scopia
- ·The full record, as it builds
Funding rounds
No funding rounds for Scopia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Scopia
Developer of colonoscopy quality monitoring software designed to track procedure performance and support quality improvement in endoscopy units. The company provides a cloud-based platform that captures procedure data, calculates key quality metrics, and presents results through dashboards, enabling hospitals and clinics to monitor performance and standardize quality assessment across providers.
- Sector
- Healthcare
- HQ
- Helsinki, Finland
- Founded
- 2024
- Employees
- 3
- Website
- scopia.app/
- Ownership
- Privately Held (backing)
Scopia doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Scopia shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Scopia in its N-PORT filings yet. We sweep new filings monthly.